LSR
CEL-SCI Corporation · GETTEX:LSR
1.20 EUR0.00 0.00%
CEL-SCI Corporation (GETTEX:LSR) last traded at 1.20 EUR, unchanged on the day. Over the past year the stock is down 13.67%. Its 52-week range is 1.16 to 2.42. It is in the Health Technology sector (Biotechnology).
Key statistics
Open1.20
Day range1.20 – 1.20
52-week range1.16 – 2.42
Volume0
Average volume (10 days)182
Market cap (USD)24.27 M
EPS (TTM) (USD)−2.58
Dividend yield0.00%
Beta (1 year)2.48
Revenue (TTM) (USD)0
Performance
−16.67%1 week
−38.46%1 month
−13.67%3 months
−13.67%6 months
−13.67%Year to date
−13.67%1 year
Technical reading
Bearish
Daily summary of what 11 oscillators and 15 moving averages show. See every indicator
Latest headlines
- CEL-SCI Presents New Phase 3 Multikine® Data at World Congress: Pre-Surgical Biomarkers Identify Head & Neck Cancer Patients Achieving 73% 5-Year SurvivalBusinessWire · 26 Oct 2026
- CEL-SCI Invited to Deliver Keynote Address on Multikine at 6th World Congress on Otology, Rhinology and LaryngologyBusinessWire · 15 Sep 2026
- Cancer immunotherapy developer CEL-SCI's Q3 net loss unchangedReuters · 17 Aug 2026
- CEL-SCI 3Q Loss/Shr 47c >CVMDow Jones Newswires · 17 Aug 2026
- CEL-SCI 3Q Research and Development Expenses $3.6M >CVMDow Jones Newswires · 17 Aug 2026
- BRIEF-CEL-SCI Corporation Q2 EPS USD -0.47Reuters · 17 Aug 2026
- CEL-SCI Reports Fiscal Third Quarter 2026 ResultsBusinessWire · 17 Aug 2026
- CEL-SCI Study Published in Peer-Reviewed Oral Oncology Supports Multikine's Biomarker Strategy and Potential Overall Survival Benefit Ahead of Head and Neck Cancer Confirmatory Registration StudyBusinessWire · 04 Aug 2026
Market data is delayed as each exchange requires (see data coverage). SuperCharting is charting software and gives no investment advice.